Potential of Unengineered and Engineered Wharton’s Jelly Mesenchymal Stem Cells as Cancer Inhibitor Agent

Publisher： Bentham Science Publishers

E-ISSN： 1875-6115|15|2|128-137

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.15, Iss.2, 2015-08, pp. : 128-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxic Culture Conditions for Mesenchymal Stromal/Stem Cells from Wharton’s Jelly: A Critical Parameter to Consider in a Therapeutic Context

By  

Current Stem Cell Research & Therapy, Vol. 9, Iss. 4, 2014-07 ,pp. : 306-318

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Wharton’s Jelly Derived Fetal Mesenchymal Cells with Tumor Cells

By  

Current Stem Cell Research & Therapy, Vol. 9, Iss. 6, 2014-11 ,pp. : 504-507

Bentham Science Publishers

Access to resources Recommend Favorite

New Frontiers in Regenerative Medicine in Cardiology: The Potential of Wharton's Jelly Mesenchymal Stem Cells

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 1, 2013-01 ,pp. : 39-45

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells Derived from Wharton's Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 2, 2013-03 ,pp. : 144-155

Bentham Science Publishers

Access to resources Recommend Favorite

Human Wharton's Jelly Mesenchymal Stem Cells Maintain the Expression of Key Immunomodulatory Molecules When Subjected to Osteogenic, Adipogenic and Chondrogenic Differentiation In Vitro: New Perspectives for Cellular Therapy

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 1, 2013-01 ,pp. : 100-113

Bentham Science Publishers

Access to resources Recommend Favorite